Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) Cost of Revenue: 2022-2023

Historic Cost of Revenue for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to $80,027.

  • Mainz Biomed N.V's Cost of Revenue fell 49.02% to $80,027 in Q4 2023 from the same period last year, while for Dec 2023 it was $385,820, marking a year-over-year increase of 10.96%. This contributed to the annual value of $319,108 for FY2024, which is 17.29% down from last year.
  • Latest data reveals that Mainz Biomed N.V reported Cost of Revenue of $80,027 as of Q4 2023, which was down 15.30% from $94,483 recorded in Q3 2023.
  • In the past 5 years, Mainz Biomed N.V's Cost of Revenue registered a high of $156,985 during Q4 2022, and its lowest value of $54,136 during Q1 2022.
  • In the last 2 years, Mainz Biomed N.V's Cost of Revenue had a median value of $87,255 in 2023 and averaged $91,693.
  • Examining YoY changes over the last 5 years, Mainz Biomed N.V's Cost of Revenue showed a top increase of 105.34% in 2023 and a maximum decrease of 49.02% in 2023.
  • Quarterly analysis of 2 years shows Mainz Biomed N.V's Cost of Revenue stood at $156,985 in 2022, then crashed by 49.02% to $80,027 in 2023.
  • Its Cost of Revenue was $80,027 in Q4 2023, compared to $94,483 in Q3 2023 and $100,147 in Q2 2023.